Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Dia europe 2025

    1 min read

    DIA Europe

    Meet Veristat at DIA Europe, March 18-20, 2025 

    Join us at DIA Europe 2025, the largest neutral life sciences conference in the region, where science, innovation, and regulatory experts converge. 

    Veristat is a global, science-driven CRO and consultancy dedicated to accelerating the development, approval, and commercialization of groundbreaking therapies. With flexible, scalable engagement models for clinical trial planning, execution, regulatory affairs and strategic consulting, we help Sponsors bring life-changing treatments to patients worldwide. 

    March 18-20, 2025, Congress Center Basel, Switzerland 

    DIA Europe is the largest neutral life sciences conference in the region, bringing together leaders from science, healthcare, patient advocacy, and regulatory sectors. Veristat experts will be on-site, ready to discuss how Veristat’s tailored solutions can help navigate the complexities of the European market and beyond. 

    Let’s connect. Schedule a meeting with Veristat today.  

    Veristat Attendees: 

     Beatrice Oberle-Rolle – VP Quality Assurance and Pharmacovigilance 
    Anja Bührer - VP Regulatory Affairs 

    Conference Details: 

    Date: March 18-20, 2025 
    Location: Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland 

    Schedule a Meeting:  

    Fill out the form to schedule a meeting with our experts and explore how Veristat can accelerate your clinical trials, regulatory submissions, and market access strategies toward success. 

    Learn more about the conference

     

     

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...